.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
US Department of Justice
Federal Trade Commission
Accenture
Express Scripts
UBS
Cantor Fitzgerald
Boehringer Ingelheim
Teva

Generated: November 20, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: tofacitinib citrate

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Pf Prism Cv
XELJANZ
tofacitinib citrate
TABLET;ORAL203214NDAPfizer Laboratories Div Pfizer Inc0069-1001-0160 TABLET, FILM COATED in 1 BOTTLE (0069-1001-01)
Pf Prism Cv
XELJANZ
tofacitinib citrate
TABLET;ORAL203214NDAPfizer Laboratories Div Pfizer Inc0069-1001-02180 TABLET, FILM COATED in 1 BOTTLE (0069-1001-02)
Pf Prism Cv
XELJANZ
tofacitinib citrate
TABLET;ORAL203214NDAPfizer Laboratories Div Pfizer Inc0069-1001-0328 TABLET, FILM COATED in 1 BOTTLE (0069-1001-03)
Pf Prism Cv
XELJANZ
tofacitinib citrate
TABLET;ORAL203214NDAU.S. Pharmaceuticals63539-012-0260 TABLET, FILM COATED in 1 BOTTLE (63539-012-02)
Pfizer Inc
XELJANZ XR
tofacitinib citrate
TABLET, EXTENDED RELEASE;ORAL208246NDAPfizer Laboratories Div Pfizer Inc0069-0501-1414 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-0501-14)
Pfizer Inc
XELJANZ XR
tofacitinib citrate
TABLET, EXTENDED RELEASE;ORAL208246NDAPfizer Laboratories Div Pfizer Inc0069-0501-3030 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-0501-30)
Pfizer Inc
XELJANZ XR
tofacitinib citrate
TABLET, EXTENDED RELEASE;ORAL208246NDAU.S. Pharmaceuticals63539-501-1414 TABLET, EXTENDED RELEASE in 1 BOTTLE (63539-501-14)
Pfizer Inc
XELJANZ XR
tofacitinib citrate
TABLET, EXTENDED RELEASE;ORAL208246NDAU.S. Pharmaceuticals63539-501-3030 TABLET, EXTENDED RELEASE in 1 BOTTLE (63539-501-30)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Boehringer Ingelheim
Teva
Fish and Richardson
QuintilesIMS
Harvard Business School
McKinsey
Deloitte
UBS
Johnson and Johnson

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot